Solara Active (SOLARA)
TurnaroundFairStock Score: 10/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹512.3 |
| Market Cap | ₹2,471.76 Cr |
| P/E Ratio | 0 |
| ROCE | 6.01% |
| ROE | -2% |
| Dividend Yield | 0% |
| Profit Growth | 43.1% |
| Debt/Equity | 0.55 |
| Sales Growth | 19.6% |
| Promoter Holding | 42% |
| 52-Week Range | ₹422 — ₹774 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹287.12 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I look for businesses I can understand, with durable moats and earnings to value. Solara Active fails my first test: there are no earnings to value. At ₹498.65, the market cap is ₹2,056 Cr, but book value is only ₹227.39 per share, so I am paying 2.19 times book for a business earning a negative return on equity of -2%. Graham would demand a margin of safety; here the P/B does not compensate for a loss-making year. The latest quarter tells the same story: ₹349 Cr in sales but a ₹17 Cr net loss, roughly a -5% margin. Sales grew 16.21%, yet profit growth collapsed by -232.01%, meaning the growth is being bought with poor economics. The Piotroski F-Score of 4/9 reinforces my concern about weak financial health. Debt-to-equity of 0.51 is not alarming, and ROCE of 6.01% is positive, but those returns are far below what I want from an investment. The stock trades closer to its 52-week low of ₹422 than its high of ₹712, and the market is clearly skeptical. There is no dividend, so a patient owner gets no cash while waiting for a turnaround. Promoter holding of 42% is a positive, but it does not change the math. I would need evidence of a genuine turnaround: narrowing losses, improving margins, a rising ROCE, and several quarters of credible profitability. Until then, this is not an investment; it is speculation. I will pass and wait for better odds elsewhere.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer